LAP-BAND SYSTEM
Report
- Report Number
- 3013508647-2024-00069
- Event Type
- Injury
- Date Received
- November 19, 2024
- Date of Event
- June 7, 2024
- Report Date
- February 10, 2025
- Manufacturer
- RESHAPE LIFESCIENCES
- Product Code
- LTI
- UDI-DI
- 00850007764654
- PMA / PMN Number
- P000008
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- IN, US
- Reporter Occupation
- RISK MANAGER
- Health Professional
- N
Narratives
A LETTER WAS RECEIVED FROM FDA MEDWATCH PROGRAM WITH REPORT # MW5162807; THE REPORT WAS REVIEWED IT AND WAS DISCOVERED THAT THIS REPORT IS THE SAME AS THE MW515979 REPORT SENT TO APOLLO ENDOSURGERY, INC. ON (B)(6) 2024. WE CONSIDER THIS A DUPLICATE REPORT AND WILL NOT DOCUMENT IT AS A NEW COMPLAINT. CONSEQUENTLY, A NEW MDR WILL NOT BE SUBMITTED. A RESPONSE WAS SENT TO FDA WITH THE EXPLANATION IN (B)(6), 2024.
THE REPORTED DEVICE WAS NOT AVAILABLE FOR PHYSICAL EVALUATION. THE INVESTIGATION INVOLVED COMMUNICATION VIA EMAIL WITH THE REPORTER TO CLARIFY THE DESCRIPTION OF THE EVENT, AND THE ANALYSIS OF RELEVANT INFORMATION PROVIDED IN VIEW OF SUPPORTING THE IDENTIFICATION OF POSSIBLE CAUSES FOR THE ADVERSE EVENT. THE INVESTIGATION INVOLVED THE ANALYSYS OF THE LOT HISTORY RECORDS OF THE LAP-BAND DEVICE INVOLVED. LOT HISTORY RECORD WAS REVIEWED, AND NO DISCREPANCIES OR NON-CONFORMANCE'S WERE RECORDED. THE PRODUCT WAS MANUFACTURED ACCORDING TO SPECIFICATIONS. NO NEW RISKS IDENTIFIED, THE CURRENT RISK IS IDENTIFIED WITH A LOW RATE OF OCCURRENCE FOR THE REPORTED COMPLAINT CATEGORIES. NO CORRECTION OR CORRECTIVE ACTION REQUIRED. LIMITED INVESTIGATION DOES NOT LEAD TO A CLEAR CONCLUSION ABOUT THE CAUSE OF THE REPORTED ADVERSE EVENT.
REPORT # MW5162807 WAS RECEIVED THROUGH FDA'S MEDWATCH PROGRAM. THE REPORT RECEIVED IS A DUPLICATE OF REPORT # MW5159479. THE PATIENT PRESENTED WITH MILD EPIGASTRIC PAIN AND REFLUX AND UPPER ENDOSCOPY WAS PERFORMED, WHICH REVEALED ERODED LAP-BAND AND LAP BAND REMOVAL WAS RECOMMENDED. LAP BAND WAS FOUND PENETRATING IN THE CARDIA ON THE GREATER CURVE SIDE. NO INFLAMMATION WAS REALLY NOTED. THE SURGEON CUT THE LAP BAND INTO PIECES TO REMOVE AND ONE WAS LEFT BEHIND, WHICH THEY HAD TO GO BACK TO RETRIEVE.
REPORT, (MW5159479) WAS RECEIVED THROUGH FDA'S MEDWATCH PROGRAM. THE PATIENT PRESENTED WITH MILD EPIGASTRIC PAIN AND REFLUX AND UPPER ENDOSCOPY WAS PERFORMED, WHICH REVEALED ERODED LAP-BAND AND LAP BAND REMOVAL WAS RECOMMENDED. LAP BAND WAS FOUND PENETRATING IN THE CARDIA ON THE GREATER CURVE SIDE. NO INFLAMMATION WAS REALLY NOTED. THE SURGEON CUT THE LAP BAND INTO PIECES TO REMOVE AND ONE WAS LEFT BEHIND, WHICH THEY HAD TO GO BACK TO RETRIEVE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2314066 | LAP-BAND SYSTEM | ADJUSTABLE GASTRIC BAND | LTI | RESHAPE LIFESCIENCES | 75EA2685 | 00850007764654 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown | Required Intervention |